A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home AIMD Companies Boston Scientific Boston Scientific Acquires and Launches Fixate Tissue Band for Spinal Cord Stimulator Leads and Pain Pump Catheters
formats

Boston Scientific Acquires and Launches Fixate Tissue Band for Spinal Cord Stimulator Leads and Pain Pump Catheters

Fixate Tissue Band for Spinal Cord Stimulator Leads and Pain Pump Catheters David Prutchi PhD www.implantable-device.com

Boston Scientific announced today that it has acquired the fiXate™ Tissue Band and is launching it in the United States.   The fiXate Tissue Band is intended to be an accessory to the leads/catheter component of Spinal Cord Stimulator/Pain Pump systems functioning to secure the lead to the fascia or inter-spinous/supra-spinous ligament.  According to the press release:

“The fiXate Tissue Band is a novel suturing device that is designed to enable quick and simple placement of a suture to help secure a spinal cord stimulator (SCS) lead or pain pump catheter. Boston Scientific introduced the device earlier this month at the annual meeting of the American Academy of Pain Medicine in Fort Lauderdale. The product was purchased from Anulex Technologies, Inc.

Designed to manage chronic pain, spinal cord stimulators deliver electrical pulses from an implantable pulse generator to leads with stimulating contacts in order to mask pain signals traveling to the brain. More than 100 million Americans suffer from chronic pain, according to the American Pain Foundation. Living in constant pain for an extended period of time can have a devastating impact on quality of life.

“Anchoring a lead can be a time consuming part of the SCS procedure, and lead migration resulting in the need for revision is a known complication of SCS,” said Richard Bowman, M.D., of the Center of Pain Relief in Charleston, West Virginia. “The fiXate device improves the surgical technique by allowing the lead anchor to be secured tightly to tissue in a quick and efficient way with a small anchoring incision.”

Bench test data show that, on average, the fiXate Tissue Band can place a suture in under one minute. The semi-automated design provides ease of use for physicians and offers a minimally invasive inline design.

“We are pleased to add the fiXate device to our expanding Neuromodulation portfolio,” said Maulik Nanavaty, president, Neuromodulation, Boston Scientific. “We believe the fiXate device is a significant advance for lead securement, and this acquisition demonstrates our commitment to bringing to the market innovations that are designed to improve patient outcomes.”

 

 

 

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Acquires and Launches Fixate Tissue Band for Spinal Cord Stimulator Leads and Pain Pump Catheters  comments